Screening of prostate cancer with PSA and transperineal six sextant biopsy

2Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Abstract

(Object) The objectives of this study are to examine how many cancer patients we can detect among the outpatients whose PSA values are above 4.0 ng/ml, and to compare the usefulness of transperineal six sextant biopsy (ss- biopsy) with that of transrectal one. (Methods) All the male outpatients (above 50 years old) were inspected Tandem-R PSA levels and digital rectal examination (DRE). Among them, 129 patients showed more than 4.0 ng/ml of PSA values and/or positive finding of DRE, and underwent subsequent transperineal ss-biopsy. (Results) Cancers were detected in 52 patients (40.3%) without major complications. Among 64 gray zone (PSA 4.1~10.0 ng/ml) patients, 17 (26.6%) were found to be cancer by ss-biopsy, meanwhile only 2 cancer patients (8.9%) were detected from 23 gray zone ones by traditional directed biopsy. Application of PSA density could not be found practicable to eliminate unnecessary biopsies in the gray zone group. (Conclusion) Prostate cancer could be found nearly a fourth in the gray zone group of the outpatients. To enhance the detection rate, obtaining at least 6 core samples are recommended from either perineal or rectal root.

Cite

CITATION STYLE

APA

Ishidoya, S., Ogata, Y., Inaba, Y., Ota, S., Saito, H., Yamashita, Y., & Ohnuma, T. (1999). Screening of prostate cancer with PSA and transperineal six sextant biopsy. Japanese Journal of Urology, 90(5), 579–585. https://doi.org/10.5980/jpnjurol1989.90.579

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free